AI Diagnostic Support Tool for Diagnosis

(INTERLACE Trial)

AM
NB
Overseen ByNicholas Bishop, BA
Age: 65+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

Older adults commonly experience diagnostic errors that may lead to direct harms and increased healthcare costs. Older adults are especially at risk because of higher rates of comorbidity burden, medical complexity, frailty, and cognitive impairment. An artificial intelligence (AI) clinical decision support system (CDSS) offer a promising approach to promote diagnostic excellence for older adults.

The purpose of this study is to assess the acceptability and feasibility of a new AI CDSS for older adults in primary care. The goal of this AI CDSS is to provide diagnostic support during primary care visits (i.e., help make timely and accurate diagnoses) and support communication amongst patients, doctors, and caregivers about the patient's health.

In this study, participants will use the AI CDSS in a primary care visit and review its suggestions for diagnoses and tests. Afterwards, they will complete a feedback survey and interview where they share their thoughts about and experience using the AI CDSS.

Who Is on the Research Team?

GE

Gary E Weissman, MD, MSPH

Principal Investigator

University of Pennsylvania

Are You a Good Fit for This Trial?

Inclusion Criteria

Clinicians
1. Work in the University of Pennsylvania Health System
2. Work in a primary care setting (i.e., Internal Medicine, Geriatric Medicine, Family Medicine, and Penn Primary Care)
See 7 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Primary Care Visit

Participants use the AI CDSS during a primary care visit to input symptoms and review diagnostic suggestions

1 day
1 visit (in-person)

Feedback and Interview

Participants complete a feedback survey and interview to share their thoughts and experiences using the AI CDSS

Up to 2 weeks

Follow-up

Participants are monitored for any additional feedback or issues post-intervention

2 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Artificial intelligence-based diagnostic support tool

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Use of INTERLACE tool in primary care visitExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Penn Artificial Intelligence and Technology (PennAITech) Collaboratory for Healthy Aging

Collaborator

National Academy of Medicine (NAM)

Collaborator